CS-1036 phase 2 study - dose response study of CS-1036 in patients with type 2 diabetes -
Latest Information Update: 09 May 2018
At a glance
- Drugs CS 1036 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 24 May 2016 New trial record